semaglutide gastric intestinal obstruction lawsuit in kentucky gi class action law firm Ozempic for Blindness, Stomach Paralysis and Injury Claims Semaglutide (Ozempic) carries FDA warnings – kentucky semaglutide gastric intestinal obstruction

A 2021 analysis of semaglutide trials published in Obesity found that approximately 40% of weight lost on GLP-1 medications came from lean mass rather than fat, a finding that has been replicated across multiple trials since

WADA does not name it

Sage Canaday, a masters ultra, trail, and mountain runner, accused Hanes of using a banned substance called BPC-157, and filed a tip with the United States Anti-Doping Agency (USADA), claiming that Hanes had touted his use of it on Instagram and his podcast

Transient receptor potential mucolipin 1 (TRPML1) Lysosomal exocytosis is crucial for maintaining lysosomal homeostasis